[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356318-105":59,"doc-detail-356318-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","biomimetic-pd-1-nanovesicles-inducing-tri-modal-sonodynamic-chemo-immunotherapy-for-breast-cancer-therapy-and-lung-metastasis-inhibition","Biomimetic PD-1 Nanovesicles Inducing Tri-Modal Sonodynamic-Chemo-Immunotherapy for Breast Cancer Therapy and Lung Metastasis Inhibition","","Breast cancer therapies show constrained effectiveness and often fail to control tumor metastasis, creating a strong need for innovative treatment modalities. A PD-1+ cell membrane-coated nanoplatform (PD-1-Au@DOX) was developed to combine ultrasound-responsive gold nanoparticles, doxorubicin delivery, and PD-L1 blockade. Ultrasound induced ROS generation, glutathione depletion, and enhanced DOX release, producing strong apoptosis in breast cancer cell lines. In murine models, the approach suppressed primary tumors and coordinated PD-1/PD-L1 immune activation with US-mediated ferroptosis to inhibit lung metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomimetic-pd-1-nanovesicles-inducing-tri-modal-sonodynamic-chemo-immunotherapy-for-breast-cancer-therapy-and-lung-metastasis-inhibition/356318/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomimetic-pd-1-nanovesicles-inducing-tri-modal-sonodynamic-chemo-immunotherapy-for-breast-cancer-therapy-and-lung-metastasis-inhibition/356318.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What tri-modal components are integrated in PD-1-Au@DOX?","Question",{"text":112,"@type":113},"PD-1-Au@DOX combines ultrasound-responsive gold nanoparticles, doxorubicin delivery, and PD-L1 blockade within a PD-1 cell membrane-coated nanoplatform.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does ultrasound enhance therapeutic effects in this system?",{"text":117,"@type":113},"Under ultrasound irradiation, the gold nanoparticles generate substantial reactive oxygen species (ROS), deplete intracellular glutathione, and increase doxorubicin release, driving apoptosis in breast cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What results are reported for breast cancer metastasis in animal models?",{"text":121,"@type":113},"In murine breast cancer models, PD-1-Au@DOX plus ultrasound showed strong primary tumor suppression and coordinated immune activation that effectively suppressed lung metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356318,1790465783,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Lin etal. Journal of Nanobiotechnology (2026) 24:116 Journal of Nanobiotechnology  \n[https://doi.org/10.1186/s12951-025-04013-6](https://doi.org/10.1186/s12951-025-04013-6)  \nRESEARCH Open Access  \nBiomimetic PD-1-nanovesicles inducing tri- modal sonodynamic-chemo-immunotherapy for breast cancer therapy and lung metastasis inhibition  \nWenjin Lin1†, Zhenhu Lin1†, Fen Fu1, Zhiyong Li1, Haidong Dong2, Leilei Liu3*, Xiaodong Xie4* and Xiujuan Zhang1*  \nAbstract  \nBackground Current cancer therapeutic approaches demonstrate constrained efficacy and fail to effectively address tumor metastasis, underscoring the critical need for innovative treatment modalities.  \nResults In this study, we developed an innovative PD-1+ cell membrane-coated nanoplatform (PD-1-Au@DOX) that integrates ultrasound (US)-responsive gold nanoparticles (AuNPs), doxorubicin (DOX) delivery, and PD-L1 blockade into a synergistic therapeutic system. In vitro studies demonstrate that PD-1-Au@DOX enables targeted delivery of DOX and AuNPs to PD-L1-expressing breast cancer cells (4T1 and MCF-7) via surface-bound PD-1, while concurrently blocking PD-L1 to initiate an immune response. Under US irradiation, AuNPs generate substantial reactive oxygen species (ROS), deplete intracellular glutathione, and increase DOX release. The synergistic interplay of these three pathways culminates in pronounced apoptosis in both 4T1 and MCF-7 cell lines. In murine breast cancer models, PD-1-Au@DOX + US demonstrated significant efficacy in primary tumor suppression, as evidenced by robust growth inhibition and prolonged survival. The coordinated activation of immune responses through PD-1/PD-L1 pathway modulation and US-mediated ferroptosis effectively suppressed lung metastasis.  \nConclusions These findings establish PD-1-Au@DOX + US as a tri-modal approach for breast cancer treatment and metastasis prevention, providing an effective new clinical pathway.  \nKeywords Breast cancer, Metastasis prevention, Sonodynamic therapy, Chemotherapy, Immunotherapy  \n†Wenjin Lin, Zhenhu Lin, These authors contributed equally.  \n*Correspondence:  \nLeilei Liu [liull8675@126.com](liull8675@126.com)[ ](liull8675@126.com)Xiaodong Xie [fantasyxiaodong@163.com](fantasyxiaodong@163.com)[ ](fantasyxiaodong@163.com)Xiujuan Zhang [jenifer81@126.com](jenifer81@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026, modified publication 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercialNoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://cre](http://cre)[ativecommons.org/licenses/by-nc-nd/4.0/](ativecommons.org/licenses/by-nc-nd/4.0/.)[.](ativecommons.org/licenses/by-nc-nd/4.0/.)  \nLin et al. Journal of Nanobiotechnology (2026) 24:116 Page 2 of 18  \nGraphical Abstract  \nIntroduction  \nBreast cancer remains one of the most prevalent cancers worldwide [1]. The current standard of care for breast cancer, which includes surgical resection, radiotherapy, chemotherapy, and immunotherapy, continues to yield suboptimal outcomes. This limited efficacy is largely attributable to the constraints of indivi","cbCaireNB6vPE3KN","https://ap.wps.com/l/cbCaireNB6vPE3KN","pdf",3695637,18,"English","# Abstract\n## Background\n## Results\n## Conclusions\n# Introduction\n## Breast cancer treatment limitations\n## Sonodynamic therapy advantages and challenges\n## Cancer immunotherapy and immune checkpoint inhibitors","[{\"question\":\"What tri-modal components are integrated in PD-1-Au@DOX?\",\"answer\":\"PD-1-Au@DOX combines ultrasound-responsive gold nanoparticles, doxorubicin delivery, and PD-L1 blockade within a PD-1 cell membrane-coated nanoplatform.\"},{\"question\":\"How does ultrasound enhance therapeutic effects in this system?\",\"answer\":\"Under ultrasound irradiation, the gold nanoparticles generate substantial reactive oxygen species (ROS), deplete intracellular glutathione, and increase doxorubicin release, driving apoptosis in breast cancer cells.\"},{\"question\":\"What results are reported for breast cancer metastasis in animal models?\",\"answer\":\"In murine breast cancer models, PD-1-Au@DOX plus ultrasound showed strong primary tumor suppression and coordinated immune activation that effectively suppressed lung metastasis.\"}]","Biomimetic PD-1 Nanovesicles Inducing Tri-Modal Sonodynamic-Chemo-Immunotherapy for Breast Cancer Therapy and Lung Metastasis Inhibition | PDF",1790124661,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfd83ce515ff5d4dc25cb7fc2b54f965.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e168916b4fda1242858a9deeef77eaf9.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da50cf387cee909da99629cf3e6c646e.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e692fd5457564f20e298681659e112a5.webp",980,1306]